​Rulemaking Published

Date: 
Wednesday, July 29, 2020

Rulemaking action by the Iowa Board of Pharmacy has been published in the Iowa Administrative Bulletin as follows: 

Notice of Intended Action

ARC 5113C has been published as a Notice of Intended Action to amend:

  • Chapter 1, “Purpose and Organization,”

  • Chapter 2, “Pharmacist Licenses,”

  • Chapter 8, “Universal Practice Standards,”

  • Chapter 13, “Telepharmacy Practice,”

  • Chapter 16, “Nuclear Pharmacy Practice,”

  • Chapter 26, “Petitions for Rule Making,”

  • Chapter 34, “Rules for Waivers and Variances,” and

  • Chapter 39, “Expanded Practice Standards.”

  • The proposed amendments bring the Board’s rules in alignment with Iowa Code changes made during the 2019 and 2020 legislative sessions and include:

    • Oversight of the Board’s Executive Director (2019 Iowa Acts, House File 766),

    • Service animals or service-animals-in-training (2019 Iowa Acts, Senate File 341),

    • Extension of the repeal date of the authorization for physician-signed immunization protocols (2020 Iowa Acts, House File 2627), 

    • Waivers and variances (2020 Iowa Acts, House File 2389), and 

    • Submission of the disposition of a petition for rule making to the Administrative Rules Review Committee (2020 Iowa Acts, House File 2389).

  • Comments may be submitted no later than 4:30pm on August 18, 2020.

ARC 5114C has been published as a Notice of Intended Action to amend Chapter 10, “Controlled Substances,” and Chapter 11, “Drugs in Emergency Medical Service Programs.”

  • The proposed amendments:

    • Clarify the expectation that a registrant’s perpetual inventory must at all times accurately reflect the actual on-hand inventory of the substances, and

    • Simplify the rule relating to the purchase of Schedule I and II substances in response to amendments to federal regulations allowing a new single page DEA Form 222 while still allowing use of the triplicate form for a period of time.

  • Comments may be submitted no later than 4:30pm on August 18, 2020.

ARC 5115C has published as a Notice of Intended Action to amend Chapter 8, “Universal Practice Standards” and Chapter 21, “Electronic Data and Automated Systems in Pharmacy Practice.”

  • The proposed amendments clarify that patient information which is needed for a pharmacist to conduct drug utilization review must be obtained and that the collection of that information can be delegated to a pharmacy technician. The amendments also include that an electronically transmitted prescription must include the telephone number at which the prescriber can be contacted. The amendments also update a reference.

  • Comments may be submitted no later than 4:30pm on August 18, 2020.


 

Printed from the Iowa Board of Pharmacy website on August 06, 2020 at 10:36am.